Photo: aktifinternational.com
Pancreatic cancer is often called the “silent killer” by doctors. It is one of the most challenging cancers to detect early and even harder to treat. However, new research from Johns Hopkins University (USA) offers hope for breakthroughs in understanding the disease and improving patient outcomes.
Researchers have found that a patient’s chances of recovery depend not just on the presence of immune cells in the body, but on their precise arrangement within the tumor. Previously, doctors focused mainly on the total number of immune cells attacking the cancer. The new study goes further, showing that the tumor’s architecture is crucial:
How immune cells are clustered.
Whether they are located in the center of the tumor or at its edges.
How they interact with cancer cells.
This “map” of immune cell placement affects how effectively the body responds to chemotherapy or immunotherapy, and ultimately, how long the patient may survive.
